Results 121 to 130 of about 1,823 (190)

Merging Excited-State Copper Catalysis and Triplet Nitro(hetero)arenes for Direct Synthesis of 2-Aminophenol Derivatives. [PDF]

Chem
Shah JA, Banerjee A, Mukherjee U, Ngai MY.   +3 more
europepmc   +1 more source

Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators. [PDF]

Acta Paediatr
Svedberg M, Lundqvist F, Östrand HA, Krantz C, Ekman P, Imberg H.   +5 more
europepmc   +1 more source

Reply to Piehler et al.: Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy. [PDF]

Am J Respir Crit Care Med
Duff AJA, Lee TWR.
europepmc   +1 more source

Potential side effects of toxic and restricted substances found in cosmetics declared to be of natural origin. [PDF]

Front Public Health
Koncz D, Nemeth MA, Pallagi E, Tóth B, Csupor D.   +4 more
europepmc   +1 more source

Short-term monitoring of CFTR modulator therapy in adults and children with cystic fibrosis using low and ultra-low-dose lung CT. [PDF]

Radiol Med
Maccioni F, Cimino G, Longhi A, Busato L, Valenti A, Bottino L, Rutigliano M, Alessandrelli R, Landini N, Catalano C.   +9 more
europepmc   +1 more source

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]

Pediatr Pulmonol
Kümmerli S, Elviro CF, Regamey N, Mornand A, Faouzi M, Rochat I, Blanchon S.   +6 more
europepmc   +1 more source

A Sustainable Visible Light-Mediated Synthesis of Benzoxazole 2-Carboxylates/Carboxamides. [PDF]

Chemistry
Gerogiannopoulou AD, Mountanea OG, Theodoropoulou MA, Kokotos CG, Kokotos G.   +4 more
europepmc   +1 more source

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy. [PDF]

J Cyst Fibros
Green N, Vu P, Xie J, Schwarzenberg SJ, Freedman S, Narkewicz M, Pittman J, Ratjen F, Rosenfeld M, Pope C, Duong J, Hoffman L, Heltshe S, Lusman SS, PROMISE Study Group.   +14 more
europepmc   +1 more source

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis. [PDF]

Adv Ther
Geiger JM, Brady BL, Lew CR, Jennings M, Mo C, Van Brunt K, Dezube R.   +6 more
europepmc   +1 more source

Advances in the restoration of CFTR in children and pwCF with "mild disease". [PDF]

Pediatr Pulmonol
Cohen-Cymberknoh M.
europepmc   +1 more source